carbostyril has been researched along with Brain Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hassan, H; Moawed, FSM; Nabeel, AI | 1 |
| Sikich, L | 1 |
1 review(s) available for carbostyril and Brain Disorders
| Article | Year |
|---|---|
Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain Diseases; Child; Chronic Disease; Clozapine; Comorbidity; Disease Progression; Humans; Magnetic Resonance Imaging; Olanzapine; Piperazines; Prognosis; Psychotic Disorders; Quinolones; Schizophrenia; Thiazoles; Treatment Failure | 2008 |
1 other study(ies) available for carbostyril and Brain Disorders
| Article | Year |
|---|---|
Immunomodulatory effect of new quinolone derivative against cisplatin/gamma radiation-induced renal and brain toxicity in mice.
Topics: Acute Kidney Injury; Animals; Apoptosis; Brain; Brain Diseases; Cisplatin; Gamma Rays; Immunologic Factors; Kidney; Male; Mice; Quinolones | 2018 |